315 related articles for article (PubMed ID: 27864696)
1. Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors.
Layh-Schmitt G; Lu S; Navid F; Brooks SR; Lazowick E; Davis KM; Montagna C; Gadina M; Colbert RA
Clin Rheumatol; 2017 Jan; 36(1):143-154. PubMed ID: 27864696
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity.
Kang R; Zhou Y; Tan S; Zhou G; Aagaard L; Xie L; Bünger C; Bolund L; Luo Y
Stem Cell Res Ther; 2015 Aug; 6(1):144. PubMed ID: 26282538
[TBL] [Abstract][Full Text] [Related]
3. Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration.
Tang M; Chen W; Liu J; Weir MD; Cheng L; Xu HH
Tissue Eng Part A; 2014 Apr; 20(7-8):1295-305. PubMed ID: 24279868
[TBL] [Abstract][Full Text] [Related]
4. Generation of human β-thalassemia induced pluripotent cell lines by reprogramming of bone marrow-derived mesenchymal stromal cells using modified mRNA.
Varela I; Karagiannidou A; Oikonomakis V; Tzetis M; Tzanoudaki M; Siapati EK; Vassilopoulos G; Graphakos S; Kanavakis E; Goussetis E
Cell Reprogram; 2014 Dec; 16(6):447-55. PubMed ID: 25354259
[TBL] [Abstract][Full Text] [Related]
5. Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells.
Xu M; Shaw G; Murphy M; Barry F
Stem Cells; 2019 Jun; 37(6):754-765. PubMed ID: 30779868
[TBL] [Abstract][Full Text] [Related]
6. Differential Expression of Cholinergic System Components in Human Induced Pluripotent Stem Cells, Bone Marrow-Derived Multipotent Stromal Cells, and Induced Pluripotent Stem Cell-Derived Multipotent Stromal Cells.
Weist R; Flörkemeier T; Roger Y; Franke A; Schwanke K; Zweigerdt R; Martin U; Willbold E; Hoffmann A
Stem Cells Dev; 2018 Feb; 27(3):166-183. PubMed ID: 29205106
[TBL] [Abstract][Full Text] [Related]
7. Impaired Osteogenesis of Disease-Specific Induced Pluripotent Stem Cells Derived from a CFC Syndrome Patient.
Choi JY; Han KM; Kim D; Lee BH; Yoo HW; Choi JH; Han YM
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194391
[TBL] [Abstract][Full Text] [Related]
8. Targeted reversion of induced pluripotent stem cells from patients with human cleidocranial dysplasia improves bone regeneration in a rat calvarial bone defect model.
Saito A; Ooki A; Nakamura T; Onodera S; Hayashi K; Hasegawa D; Okudaira T; Watanabe K; Kato H; Onda T; Watanabe A; Kosaki K; Nishimura K; Ohtaka M; Nakanishi M; Sakamoto T; Yamaguchi A; Sueishi K; Azuma T
Stem Cell Res Ther; 2018 Jan; 9(1):12. PubMed ID: 29357927
[TBL] [Abstract][Full Text] [Related]
9. Efficient differentiation of human iPSC-derived mesenchymal stem cells to chondroprogenitor cells.
Guzzo RM; Gibson J; Xu RH; Lee FY; Drissi H
J Cell Biochem; 2013 Feb; 114(2):480-90. PubMed ID: 22961870
[TBL] [Abstract][Full Text] [Related]
10. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice.
Lian Q; Zhang Y; Zhang J; Zhang HK; Wu X; Zhang Y; Lam FF; Kang S; Xia JC; Lai WH; Au KW; Chow YY; Siu CW; Lee CN; Tse HF
Circulation; 2010 Mar; 121(9):1113-23. PubMed ID: 20176987
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
[TBL] [Abstract][Full Text] [Related]
13. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage.
Li F; Bronson S; Niyibizi C
J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314
[TBL] [Abstract][Full Text] [Related]
14. Generation, Characterization, and Multilineage Potency of Mesenchymal-Like Progenitors Derived from Equine Induced Pluripotent Stem Cells.
Lepage SI; Nagy K; Sung HK; Kandel RA; Nagy A; Koch TG
Stem Cells Dev; 2016 Jan; 25(1):80-9. PubMed ID: 26414480
[TBL] [Abstract][Full Text] [Related]
15. Derivation of mesenchymal stromal cells from pluripotent stem cells through a neural crest lineage using small molecule compounds with defined media.
Fukuta M; Nakai Y; Kirino K; Nakagawa M; Sekiguchi K; Nagata S; Matsumoto Y; Yamamoto T; Umeda K; Heike T; Okumura N; Koizumi N; Sato T; Nakahata T; Saito M; Otsuka T; Kinoshita S; Ueno M; Ikeya M; Toguchida J
PLoS One; 2014; 9(12):e112291. PubMed ID: 25464501
[TBL] [Abstract][Full Text] [Related]
16. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
[TBL] [Abstract][Full Text] [Related]
17. Osteogenically differentiated mesenchymal stem cells and ceramics for bone tissue engineering.
Ohgushi H
Expert Opin Biol Ther; 2014 Feb; 14(2):197-208. PubMed ID: 24308323
[TBL] [Abstract][Full Text] [Related]
18. Generation of human induced pluripotent stem cells from osteoarthritis patient-derived synovial cells.
Kim MJ; Son MJ; Son MY; Seol B; Kim J; Park J; Kim JH; Kim YH; Park SA; Lee CH; Lee KS; Han YM; Chang JS; Cho YS
Arthritis Rheum; 2011 Oct; 63(10):3010-21. PubMed ID: 21953087
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
[TBL] [Abstract][Full Text] [Related]
20. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]